In focus · trending topic

ear diseases

8 stories · following the connections

Otonomy to Report First Quarter 2018 Financial Results and Provide Corporate Update

By Nasdaq OMXMay 2, 2018, 11:31 AM UTC

Otonomy Announces Positive Top-Line Results from Phase 3 Clinical Trial of OTIPRIO® in Patients with Acute Otitis Externa

By Nasdaq OMXJan 5, 2017, 12:01 PM UTC

Otonomy Announces Positive Top-Line Results from Phase 3 Clinical Trial of OTIPRIO® in Patients with Acute Otitis Externa

By Nasdaq OMXJan 5, 2017, 12:01 PM UTC

Otonomy to Present at the J.P. Morgan Healthcare Conference

By Nasdaq OMXJan 3, 2017, 12:30 PM UTC

Otonomy Successfully Completes Phase 2 Clinical Trial of OTIPRIO® in Pediatric Patients with Acute Otitis Media with Tympanostomy Tubes

By Nasdaq OMXOct 4, 2016, 11:30 AM UTC

Otonomy to Present at Baird Global Healthcare Conference

By Nasdaq OMXSep 1, 2016, 11:30 AM UTC

Otonomy Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update

By Nasdaq OMXMar 7, 2016, 9:14 PM UTC

Otonomy Announces Publication Supporting Development of OTO-104 as Protectant Against Cisplatin-Induced Hearing Loss

By Nasdaq OMXJan 26, 2016, 12:05 PM UTC